Quality Compliance Officer & Responsible Person
Norgine
Quality Compliance Officer & Responsible Person
Norgine
European specialty pharma focused on gastroenterology
Norgine · Amsterdam, Netherlands (Hybrid) · — · Posted 2026-10-23
Workplace: hybrid
Department: Operations - Quality - NPB
At Norgine, we transform lives through innovative healthcare solutions. For over a century, we have partnered across Europe to bring life-changing medicines and medical devices to patients who need them. We are guided by our values to Drive, Dare and Develop, creating an environment where people take ownership, challenge boundaries and support each other to succeed.
We are looking for a Quality Compliance Officer and Responsible Person (RP) to provide quality oversight and ensure compliance with Wholesale Distribution Licence requirements and Good Distribution Practice (GDP) regulations. This role is critical in maintaining product quality, patient safety and regulatory compliance across one or more Norgine entities.
The ideal candidate will demonstrate our values by:
Drive
Taking ownership, delivering results and making timely decisions.
Dare
Challenging constructively, embracing innovation and finding better ways of working.
Develop
Collaborating effectively, valuing different perspectives and helping others succeed.
Why Join Norgine?
At Norgine, we support multidimensional careers where people are encouraged to dare, drive and develop. You'll join a collaborative organisation committed to improving patients' lives while providing opportunities for professional growth, learning, and meaningful impact.
Norgine is an equal opportunities employer and values diversity. We welcome applications from all qualified candidates regardless of background, identity, or experience.
Powered by Workable
Norgine is a European specialty pharmaceutical company that develops, markets, and distributes prescription medicines for gastroenterology. Its products, such as MOVICOL, work as osmotic laxatives by drawing water into the stool to soften it and increase bowel movements, and are sold across Europe. The company distinguishes itself with a long, family-led history and deep GI expertise, now backed by Goldman Sachs Asset Management’s private equity arm to pursue growth through acquisitions and new product development. Its goal is to expand its GI-focused portfolio and strengthen its European market position through strategic acquisitions and new therapies.
Explore more opportunities at Norgine